Garbarino, J., Eckroate, J., Sundaram, R. K., Jensen, R. B., & Bindra, R. S. (2021). Loss of ATRX confers DNA repair defects and PARP inhibitor sensitivity. Translational oncology, 14(9), 101147. https://doi.org/10.1016/j.tranon.2021.101147
Chicago Style (17th ed.) CitationGarbarino, Jennifer, Jillian Eckroate, Ranjini K. Sundaram, Ryan B. Jensen, and Ranjit S. Bindra. "Loss of ATRX Confers DNA Repair Defects and PARP Inhibitor Sensitivity." Translational Oncology 14, no. 9 (2021): 101147. https://doi.org/10.1016/j.tranon.2021.101147.
MLA (9th ed.) CitationGarbarino, Jennifer, et al. "Loss of ATRX Confers DNA Repair Defects and PARP Inhibitor Sensitivity." Translational Oncology, vol. 14, no. 9, 2021, p. 101147, https://doi.org/10.1016/j.tranon.2021.101147.
Warning: These citations may not always be 100% accurate.